138 related articles for article (PubMed ID: 30652922)
1. How we use pazopanib in treating soft-tissue sarcoma: experience at our multidisciplinary sarcoma centers.
Van Tine BA; Trent JC
Curr Med Res Opin; 2019 Apr; 35(4):623-629. PubMed ID: 30652922
[TBL] [Abstract][Full Text] [Related]
2. A phase II trial comparing pazopanib with doxorubicin as first-line treatment in elderly patients with metastatic or advanced soft tissue sarcoma (EPAZ): study protocol for a randomized controlled trial.
Karch A; Koch A; Grünwald V
Trials; 2016 Jul; 17(1):312. PubMed ID: 27387325
[TBL] [Abstract][Full Text] [Related]
3. A randomized, open-label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft-tissue sarcoma.
Somaiah N; Van Tine BA; Wahlquist AE; Milhem MM; Hill EG; Garrett-Mayer E; Armeson KE; Schuetze SM; Meyer CF; Reuben DY; Elias AD; Read WL; Chawla SP; Kraft AS
Cancer; 2021 Mar; 127(6):894-904. PubMed ID: 33231866
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review.
Sharma S; Takyar S; Manson SC; Powell S; Penel N
BMC Cancer; 2013 Aug; 13():385. PubMed ID: 23937858
[TBL] [Abstract][Full Text] [Related]
5. Phase Ib/II Study of the Safety and Efficacy of Combination Therapy with Multikinase VEGF Inhibitor Pazopanib and MEK Inhibitor Trametinib In Advanced Soft Tissue Sarcoma.
Subbiah V; Meyer C; Zinner R; Meric-Bernstam F; Zahurak ML; O'Connor A; Roszik J; Shaw K; Ludwig JA; Kurzrock R; Azad NA
Clin Cancer Res; 2017 Aug; 23(15):4027-4034. PubMed ID: 28377484
[No Abstract] [Full Text] [Related]
6. Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.
Stacchiotti S; Mir O; Le Cesne A; Vincenzi B; Fedenko A; Maki RG; Somaiah N; Patel S; Brahmi M; Blay JY; Boye K; Sundby Hall K; Gelderblom H; Hindi N; Martin-Broto J; Kosela H; Rutkowski P; Italiano A; Duffaud F; Kobayashi E; Casali PG; Provenzano S; Kawai A
Oncologist; 2018 Jan; 23(1):62-70. PubMed ID: 28754721
[TBL] [Abstract][Full Text] [Related]
7. The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib.
Wilding CP; Elms ML; Judson I; Tan AC; Jones RL; Huang PH
Expert Rev Anticancer Ther; 2019 Nov; 19(11):971-991. PubMed ID: 31665941
[No Abstract] [Full Text] [Related]
8. Efficacy of second and third lines of treatment in advanced soft tissue sarcomas: a real-world study.
Gutierrez-Sainz L; Martinez-Fdez S; Pedregosa-Barbas J; Peña J; Alameda M; Viñal D; Villamayor J; Martinez-Recio S; Perez-Wert P; Pertejo-Fernandez A; Gallego A; Martinez-Marin V; Zamora P; Espinosa E; Mendiola M; Feliu J; Redondo A
Clin Transl Oncol; 2023 Dec; 25(12):3519-3526. PubMed ID: 37329429
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Pazopanib-Related Heart Failure in Patients With Advanced Soft Tissue Sarcoma - A Single Institute Analysis.
Wang X; Nakano K; Shiga T; Ohmoto A; Oyakawa T; Ebihara A; Sato Y; Fukuda N; Nishizawa M; Urasaki T; Ono M; Yunokawa M; Tomomatsu J; Takahashi S
Circ J; 2024 Jan; 88(2):228-233. PubMed ID: 35314578
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue Sarcoma.
Colosia A; Khan S; Hackshaw MD; Oglesby A; Kaye JA; Skolnik JM
Sarcoma; 2016; 2016():3597609. PubMed ID: 27516726
[TBL] [Abstract][Full Text] [Related]
11. Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial.
Cho HJ; Yun KH; Shin SJ; Lee YH; Kim SH; Baek W; Han YD; Kim SK; Ryu HJ; Lee J; Cho I; Go H; Ko J; Jung I; Jeon MK; Rha SY; Kim HS
Nat Commun; 2024 Jan; 15(1):685. PubMed ID: 38263321
[TBL] [Abstract][Full Text] [Related]
12. Systemic Treatment for Adults with Synovial Sarcoma.
Desar IME; Fleuren EDG; van der Graaf WTA
Curr Treat Options Oncol; 2018 Mar; 19(2):13. PubMed ID: 29516254
[TBL] [Abstract][Full Text] [Related]
13. Salvage Therapy in Advanced Adult Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis of Randomized Trials.
Comandone A; Petrelli F; Boglione A; Barni S
Oncologist; 2017 Dec; 22(12):1518-1527. PubMed ID: 28835514
[TBL] [Abstract][Full Text] [Related]
14. [Progress in the treatment of soft tissue sarcoma in the 2023 annual meeting of the American Society of Clinical Oncology].
Zhao JL; Liu WF
Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):48-56. PubMed ID: 38246780
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Drug Monitoring of Pazopanib in Renal Cell Carcinoma and Soft Tissue Sarcoma: A Systematic Review.
Turjap M; Pelcová M; Gregorová J; Šmak P; Martin H; Štingl J; Peš O; Juřica J
Ther Drug Monit; 2024 Jun; 46(3):321-331. PubMed ID: 38723115
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of pazopanib in advanced soft tissue sarcoma in the United kingdom.
Amdahl J; Manson SC; Isbell R; Chit A; Diaz J; Lewis L; Delea TE
Sarcoma; 2014; 2014():481071. PubMed ID: 25024640
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline.
Verma S; Younus J; Stys-Norman D; Haynes AE; Blackstein M
Curr Oncol; 2007 Aug; 14(4):144-8. PubMed ID: 17710206
[TBL] [Abstract][Full Text] [Related]
18. Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
Nakano K; Takahashi S
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510588
[TBL] [Abstract][Full Text] [Related]
19. Optimal Prognostic Factors for Metastatic and Inoperable Sarcomas Treated With Pazopanib, Eribulin, and Trabectedin.
Iwai T; Hoshi M; Oebisu N; Takada N; Ban Y; Yao H; Nakamura H
In Vivo; 2023; 37(6):2634-2641. PubMed ID: 37905627
[TBL] [Abstract][Full Text] [Related]
20. Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients.
Westerdijk K; Krens SD; Steeghs N; van der Graaf WTA; Tjwa ETTL; Westdorp H; Desar IME; van Erp NP
Cancer Chemother Pharmacol; 2024 Apr; 93(4):353-364. PubMed ID: 38104304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
